Survival analysis did not reveal any significant correlation of EPHA3 mRNA with the overall survival of patients with HCC; however, in patients with MVI, higher EPHA3 mRNA was linked to shorter survival (Fig. 3f). This evidence concerns the gene EPHA3 and hepatocellular carcinoma.